Natalya Timonina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natalya Timonina has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anastasiia V. Sokolova
Institute of Cytology, Russian Academy of Sciences, 194064 Saint-Petersburg, Russia
1 shared publication Elena Mikhailova
Saint Petersburg State University, 7–9, Universitetskaya nab., Saint Petersburg, 199034, Russian Federation
1 shared publication- Igor I. Krivoi
St. Petersburg State University, St. Petersburg, Russia
1 shared publication - Violetta V. Kravtsova
Department of General Physiology, St. Petersburg State University, 199034 St. Petersburg, Russia
1 shared publication - Vyacheslav Mikhailov
Russian Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 25 September 2015
- Published by Saint Petersburg State University in Biological Communications
- No. 3,p. 66–74
Electrogenesis of end-plates of mdx mice diaphragm: effect of cell therapy
Disturbances of muscle electrogenesis are observed in a number of muscle pathologies, particularly, they are found in the mdx mice, which are a laboratory model of Duchenne myodystrophy. This myodystrophy develops due to mutations in the gene of the dystrophin protein, which controls the synthesis of this protein in the cytoskeleton. The effectiveness of therapy for such myodystrophy by methods of cellular and genetic engineering has not been studied with regard to the muscle membrane electrogenesis. In this study, two months old mdx mice were irradiated by X-ray at a dose of 3 Gy and injected intravenously by wild type bone marrow cells suspension from long bones of C57Bl/6 mice. Four months after such non-myeloablative bone marrow cells transplantation the recovery of resting membrane potentials as well as parameters of miniature end-plate potentials of mdx mice diaphragm muscle was observed. Our data show the effectiveness of the replacement of the mutant bone marrow with the bone marrow of wild type in myodystrophy caused by the deficiency in dystrophin protein synthesis. Refs 20. Figs 3. Table 1.
- 25 September 2015
- Published by Saint Petersburg State University in Biological Communications
- No. 3,p. 66–74
Open AccessElectrogenesis of end-plates of mdx mice diaphragm: effect of cell therapy
Disturbances of muscle electrogenesis are observed in a number of muscle pathologies, particularly, they are found in the mdx mice, which are a laboratory model of Duchenne myodystrophy. This myodystrophy develops due to mutations in the gene of the dystrophin protein, which controls the synthesis of this protein in the cytoskeleton. The effectiveness of therapy for such myodystrophy by methods of cellular and genetic engineering has not been studied with regard to the muscle membrane electrogenesis. In this study, two months old mdx mice were irradiated by X-ray at a dose of 3 Gy and injected intravenously by wild type bone marrow cells suspension from long bones of C57Bl/6 mice. Four months after such non-myeloablative bone marrow cells transplantation the recovery of resting membrane potentials as well as parameters of miniature end-plate potentials of mdx mice diaphragm muscle was observed. Our data show the effectiveness of the replacement of the mutant bone marrow with the bone marrow of wild type in myodystrophy caused by the deficiency in dystrophin protein synthesis. Refs 20. Figs 3. Table 1.